Viking Therapeutics ( (VKTX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viking Therapeutics’ stock is on the rise, driven by promising Phase 1 results for its obesity treatment, VK2735. This has led to strong buy ratings and high price targets. Despite some concerns over increased share selling by company executives, the market remains optimistic about the potential of VK2735 in the healthcare sector.
More about Viking Therapeutics
YTD Price Performance: -2.65%
Average Trading Volume: 3,813,483
Technical Sentiment Signal: Buy
Current Market Cap: $4.5B
For further insights into VKTX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.